Pharmacogenomics and Precision Medicine: Optimizing PPI Response The future of the Proton Pump Inhibitors (PPI) Market is increasingly shifting toward a paradigm of personalized medicine, driven by the science of pharmacogenomics. This field, which studies how genetic variation influences drug metabolism, offers the key to optimizing PPI efficacy, reducing adverse drug reactions (ADRs), and addressing the significant problem of "PPI non-responders."
The...
0 Compartilhamentos
210 Visualizações